Jack has made over 20 trades of the CTI BioPharma Corp stock since 2003, according to the Form 4 filled with the SEC. Most recently Jack exercised 40,000 units of CTIC stock worth $336,400 on 7 May 2007.
The largest trade Jack's ever made was exercising 40,000 units of CTI BioPharma Corp stock on 7 May 2007 worth over $336,400. On average, Jack trades about 13,626 units every 29 days since 2003. As of 7 May 2007 Jack still owns at least 52,000 units of CTI BioPharma Corp stock.
You can see the complete history of Jack Bowman stock trades at the bottom of the page.
Jack's mailing address filed with the SEC is C/O CELGENE CORPORATION, , WARREN, NJ, 11050.
Over the last 21 years, insiders at CTI BioPharma Corp have traded over $80,110,449 worth of CTI BioPharma Corp stock and bought 9,566,060 units worth $25,487,533 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., eAdvisors Llc Orbi Med Capit.... On average, CTI BioPharma Corp executives and independent directors trade stock every 26 days with the average trade being worth of $1,223,687. The most recent stock trade was executed by Adam R Craig on 24 January 2023, trading 85,317 units of CTIC stock currently worth $71,666.
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
CTI BioPharma Corp executives and other stock owners filed with the SEC include: